The very common vaccine ingredient at the center of J&J, AstraZeneca drama

Linking pages

Linked pages

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet https://www.thelancet.com/journals/lancet/article/piis0140-6736(20)31604-4/fulltext 2846 comments
AT&T/Verizon workers’ union urges states to regulate ISPs as utilities | Ars Technica https://arstechnica.com/tech-policy/2021/04/att-verizon-workers-union-urges-states-to-regulate-isps-as-utilities/ 85 comments
“Wearing a mask cleans nothing:” Florida judge vacates CDC travel mask mandate | Ars Technica https://arstechnica.com/science/2022/04/wearing-a-mask-cleans-nothing-florida-judge-vacates-cdc-travel-mask-mandate/ 19 comments
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM https://www.nejm.org/doi/10.1056/nejmoa2034201 4 comments
Combo COVID booster is the way to go this fall, Moderna data suggests | Ars Technica https://arstechnica.com/science/2022/04/combo-covid-booster-is-the-way-to-go-this-fall-moderna-data-suggests/ 2 comments
The Ars COVID-19 vaccine primer: 100-plus in the works, 8 in clinical trials | Ars Technica https://arstechnica.com/science/2020/05/the-ars-covid-19-vaccine-primer-100-plus-in-the-works-8-in-clinical-trials/ 0 comments
The Biotech Death of Jesse Gelsinger - The New York Times https://www.nytimes.com/1999/11/28/magazine/the-biotech-death-of-jesse-gelsinger.html 0 comments
Authorities raise red flags about AstraZeneca’s vaccine press release [Updated] | Ars Technica https://arstechnica.com/science/2021/03/authorities-raise-red-flags-about-astrazenecas-vaccine-press-release/ 0 comments